CancerX has officially been introduced by The White House as a collaborative effort between the American government and private sector. Its primary mission is to serve as a nationwide catalyst for advancing innovation in the ongoing battle against cancer, aligning with the renewed Cancer Moonshot initiative.
With close to 2 million new cases of cancer predicted for 2023 in the US, cancer remains one of the major health issues for the country. Aptar is proud to bring its digital health know-how to this fight.
In oncology, Aptar Digital Health develops digital health solutions that help support patients along their journey, for instance by tracking treatment-related symptoms, receiving personalized clinical recommendations on how to act based on their individualized treatment plan, or reinforcing their connection with their care team. By joining this initiative, we aim to create, foster, accelerate, and scale the impact of a community of innovators dedicated to reducing the burden of cancer for all people.
